Replies to post #135703 on Anavex Life Sciences Corp (AVXL)

[anders2211]

You describe exactly what happened in the same interview (nov 21) he admitted long wait for science, we are going to take our time, by the way, we will start 3 trials before dec 31 2017. hahaha good one cheers

I dont blame him, I blame myself for missing those two complete adverse statements in the same interview. Its as obvious as a toddler promising not to take candy while alone in the candy store.

He did what he is supposed to. Cest moi

[riaguy]

What’s wrong with some debt? To continually dilute shows a total lack of concern for shareholders and at todays rates, he could have raised cash through a debt offering. What we’ve ended up with is cash in the bank doing nothing and a miserable share price partially due to dilution.
Missling has shown that he’s the wrong man for the job. Not being able to start a single trial after stating that there would be three is simply inexcusable and to add to the situation there’s been no update on the condition of the patients in the Australian trial which is the least that the company should have done. The result was closing at the years low and showing no progress in curing CNS diseases. At best, we were given false hope of trials and at the worst, we were lied to in order to facilitate Missling filling the bank account.
Missling probably owns too many shares to be fired but I’m sure the BOD is taking a lot of heat from the institutional holders.